Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom

Richard F. Clark, Patrick E. McKinney, Peter B. Chase, Frank G Walter

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Allergic reactions are the most commonly reported adverse events after administration of antivenoms. Conventional horse serum-based crotalid antivenom used in the United States (Antivenin [Crotalidae] polyvalent) can lead to both immediate and delayed hypersensitivity reactions. Crotalidae polyvalent immune Fab (ovine) (CroFab; FabAV) has recently been approved for use in the United States. Experience from premarketing trials of this product and in the administration of other types of Fab, such as in digoxin poisoning, has demonstrated these fragments to be safe and effective, with a low incidence of sequella; however, allergic reactions can occur when any animal-protein derivatives are administered to human subjects. We report in detail the nature and course of allergic reactions that occurred in 4 patients treated with FabAV. Cases of anaphylaxis acute urticaria, angioedema, and delayed serum sickness are described. All reactions were easily treated with some combination of antihistamines, epinephrine, and steroids, with prompt resolution of signs and symptoms enabling further dosing of antivenom as required. Several of these cases may have resulted from batches of antivenom contaminated with Fc fragments. The overall incidence of immediate and delayed allergic reactions to this product appears so far to be lower than that reported with conventional whole-immunoglobulin G (IgG) antivenom, but postmarketing surveillance is warranted.

Original languageEnglish (US)
Pages (from-to)671-676
Number of pages6
JournalAnnals of Emergency Medicine
Volume39
Issue number6
DOIs
StatePublished - 2002

Fingerprint

Antivenins
Sheep
Hypersensitivity
Serum Sickness
Immunoglobulin Fc Fragments
Immediate Hypersensitivity
Angioedema
Histamine Antagonists
Digoxin
Incidence
Urticaria
Delayed Hypersensitivity
Anaphylaxis
Viperidae
Poisoning
Epinephrine
Horses
Signs and Symptoms
Crotalidae Polyvalent immune Fab
Immunoglobulin G

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. / Clark, Richard F.; McKinney, Patrick E.; Chase, Peter B.; Walter, Frank G.

In: Annals of Emergency Medicine, Vol. 39, No. 6, 2002, p. 671-676.

Research output: Contribution to journalArticle

Clark, Richard F. ; McKinney, Patrick E. ; Chase, Peter B. ; Walter, Frank G. / Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. In: Annals of Emergency Medicine. 2002 ; Vol. 39, No. 6. pp. 671-676.
@article{5651ff471cbe49f4a7a5e7b5d99f7c4b,
title = "Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom",
abstract = "Allergic reactions are the most commonly reported adverse events after administration of antivenoms. Conventional horse serum-based crotalid antivenom used in the United States (Antivenin [Crotalidae] polyvalent) can lead to both immediate and delayed hypersensitivity reactions. Crotalidae polyvalent immune Fab (ovine) (CroFab; FabAV) has recently been approved for use in the United States. Experience from premarketing trials of this product and in the administration of other types of Fab, such as in digoxin poisoning, has demonstrated these fragments to be safe and effective, with a low incidence of sequella; however, allergic reactions can occur when any animal-protein derivatives are administered to human subjects. We report in detail the nature and course of allergic reactions that occurred in 4 patients treated with FabAV. Cases of anaphylaxis acute urticaria, angioedema, and delayed serum sickness are described. All reactions were easily treated with some combination of antihistamines, epinephrine, and steroids, with prompt resolution of signs and symptoms enabling further dosing of antivenom as required. Several of these cases may have resulted from batches of antivenom contaminated with Fc fragments. The overall incidence of immediate and delayed allergic reactions to this product appears so far to be lower than that reported with conventional whole-immunoglobulin G (IgG) antivenom, but postmarketing surveillance is warranted.",
author = "Clark, {Richard F.} and McKinney, {Patrick E.} and Chase, {Peter B.} and Walter, {Frank G}",
year = "2002",
doi = "10.1067/mem.2002.123134",
language = "English (US)",
volume = "39",
pages = "671--676",
journal = "Annals of Emergency Medicine",
issn = "0196-0644",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom

AU - Clark, Richard F.

AU - McKinney, Patrick E.

AU - Chase, Peter B.

AU - Walter, Frank G

PY - 2002

Y1 - 2002

N2 - Allergic reactions are the most commonly reported adverse events after administration of antivenoms. Conventional horse serum-based crotalid antivenom used in the United States (Antivenin [Crotalidae] polyvalent) can lead to both immediate and delayed hypersensitivity reactions. Crotalidae polyvalent immune Fab (ovine) (CroFab; FabAV) has recently been approved for use in the United States. Experience from premarketing trials of this product and in the administration of other types of Fab, such as in digoxin poisoning, has demonstrated these fragments to be safe and effective, with a low incidence of sequella; however, allergic reactions can occur when any animal-protein derivatives are administered to human subjects. We report in detail the nature and course of allergic reactions that occurred in 4 patients treated with FabAV. Cases of anaphylaxis acute urticaria, angioedema, and delayed serum sickness are described. All reactions were easily treated with some combination of antihistamines, epinephrine, and steroids, with prompt resolution of signs and symptoms enabling further dosing of antivenom as required. Several of these cases may have resulted from batches of antivenom contaminated with Fc fragments. The overall incidence of immediate and delayed allergic reactions to this product appears so far to be lower than that reported with conventional whole-immunoglobulin G (IgG) antivenom, but postmarketing surveillance is warranted.

AB - Allergic reactions are the most commonly reported adverse events after administration of antivenoms. Conventional horse serum-based crotalid antivenom used in the United States (Antivenin [Crotalidae] polyvalent) can lead to both immediate and delayed hypersensitivity reactions. Crotalidae polyvalent immune Fab (ovine) (CroFab; FabAV) has recently been approved for use in the United States. Experience from premarketing trials of this product and in the administration of other types of Fab, such as in digoxin poisoning, has demonstrated these fragments to be safe and effective, with a low incidence of sequella; however, allergic reactions can occur when any animal-protein derivatives are administered to human subjects. We report in detail the nature and course of allergic reactions that occurred in 4 patients treated with FabAV. Cases of anaphylaxis acute urticaria, angioedema, and delayed serum sickness are described. All reactions were easily treated with some combination of antihistamines, epinephrine, and steroids, with prompt resolution of signs and symptoms enabling further dosing of antivenom as required. Several of these cases may have resulted from batches of antivenom contaminated with Fc fragments. The overall incidence of immediate and delayed allergic reactions to this product appears so far to be lower than that reported with conventional whole-immunoglobulin G (IgG) antivenom, but postmarketing surveillance is warranted.

UR - http://www.scopus.com/inward/record.url?scp=0036268765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036268765&partnerID=8YFLogxK

U2 - 10.1067/mem.2002.123134

DO - 10.1067/mem.2002.123134

M3 - Article

VL - 39

SP - 671

EP - 676

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

SN - 0196-0644

IS - 6

ER -